| |
[From A Report on Alzheimer's Disease and Current Research by Dr. Jack Diamond, scientific director of the Alzheimer Society of Canada]
About Dr. Jack Diamond
Dr. Diamond is the Scientific Director of
the Alzheimer Society of Canada. He was
formerly Associate Director for Scientific
Affairs at the Montreal Neurological Institute
at McGill University, and was the founding
Chair of the original Department of
Neurosciences when the new medical school was established
at McMaster University in Hamilton, Ontario. Dr. Diamond
is also Professor Emeritus in the Department of Psychiatry
and Behavioral Neurosciences at McMaster University, where
he continues to run his laboratory research program with
a special focus on diabetic neuropathy and on the apoE4
risk factor for Alzheimer's disease. Dr. Diamond is a longstanding
member of the grant review committees of the
Juvenile Diabetes Research Foundation International, and he
also served as a volunteer Scientific Committee reviewer and
conference speaker for the ALS Society of Canada and the
Spinal Cord Society.
Dr. Diamond received his PhD and subsequently his medical
degree at the University of London, England, after which he
did two years of post-doctoral research at Harvard Medical
School, returning to a faculty position at University College
London. He is widely published, having written more than
70 papers in refereed journals, and 15 book chapters.
[The contents of this page are provided for information purposes only and do not represent advice, an endorsement or a recommendation, with respect to any product, service or enterprise, and/or the claims and properties thereof, by the Alzheimer Society of Canada. The information contained in this report was current at the time of printing, April 2008.]
|
